Traws Pharma Advances COVID-19 Treatment into First Human Trials
NEWTOWN, PA — Traws Pharma, Inc. announced this week the completion of dosing in the first cohort of a groundbreaking Phase 1 study on travatrelvir (TRX01), an innovative oral protease …
Traws Pharma Advances COVID-19 Treatment into First Human Trials Read More